Who remembers Ismail Kola?

Discussion in 'Merck' started by Anonymous, Nov 20, 2014 at 12:45 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    He was head of research in Rahway for a time. He had a reputation at Upjohn of chasing women. He a pompous ass. I remember the day he was summoned to WH, and never appeared in RY again.
     

  2. Anonymous

    Anonymous Guest

    Another loser in a long string of losers that continue today.
     
  3. Anonymous

    Anonymous Guest

    He had the balls to show up in KNW declaring himself as the "Father of Januvia". The compound was already in Phase II when he showed up at Merck. He certainly was a pompous ass. We are all good to be rid of him. Let UCB pay him for nothing.
     
  4. anonymous

    anonymous Guest

    Haha, ismail kola still talks about how he invented januvia at Ucb!!!!!
     
  5. anonymous

    anonymous Guest

    He is such a loser. Must have self esteem issues.
     
  6. anonymous

    anonymous Guest

    usb just announced internally that Ismail was "retiring" effective immediately. Unclear if this was tied to his sale of several million euros worth of ucb prior to the news of safety imbalance in a phase 3 trial. He will be hard to replace. We will all miss his comb over and pompous style
     
  7. anonymous

    anonymous Guest

    Wasn't he in Moby Dick?
     
  8. anonymous

    anonymous Guest

    Ismail Kola was retiring anyway, but he made a decision to sell all his shares right before the Evenity results and was then accused of insider trading, so the CEO of UCB decided to hang him out to dry. Ismail was a polarising character and he either loved you or hated you, and people loved him or hated him.
     
  9. anonymous

    anonymous Guest

    Is he related to Coca?
     
  10. anonymous

    anonymous Guest

    Regardless of the reason, lovely to see him go. very long overdue - he achieved nothing at UCB and caused immense disruption; the pipeline is poorer for his input. The most arrogant and over-inflated ego I've seen in 30 years in Pharma, with nothing of substance to support it. Maybe the trading issue will continue to haunt him.
     
  11. anonymous

    anonymous Guest

    At UCB his 'motivational' speeches consisted largely of droning on at great length about himself, his evident self-admiration was stomach-turning. He seemed to show no human empathy whatsoever, probably his most significant act was to make about a quarter of the research staff redundant a couple of years ago and re-hire, supposedly to 're-align' research. Just after the redundancies were announced he strutted around the Slough site asking people what they thought of 'his changes' (no doubt expecting a lot of ass-licking) and was apparently genuinely surprised that people were upset that their friends and colleagues had been sacked. Many of his research collaborations seemed more aimed at securing personal favor with senior academics in major institutions than delivering any genuine value to UCB, it is no surprise that his final act was to line his pockets. It is a mystery how people like him can screw up and then have no problem securing another senior position.
     
  12. anonymous

    anonymous Guest

    Never had a issue with him. Stop spreading rumors that never happened. They were the ones with the issues. Not him. It's a classic case of no meaning yes. He never got in trouble so it never happened. He was the last great leader here. Always treated people with respect if they deserved it.

    A great guy.
     
  13. anonymous

    anonymous Guest

    Dont forget Ismail NEVER joined Trumps Council - one step purer than a quitter

    FIRE KEN HIRE ISMAIL !!
     
  14. anonymous

    anonymous Guest

    All who shitted on Ismail Kola while at Merck or UCB, you should know this - Ismail was what was needed to kick some lazy, never ending, tea-drinking, union complaining, Monday/Friday home-working British-Belgian scientists' ass. Ultimately he was forced into retirement by UCB's CEO JC Tellier, whose paradoxical "first-in-man, transformational, first-into-market, best-in-class" strategy in rheumatology is going to hit UCB hard very soon.

    We will miss Ismail Kola.

    Hopefully, New Meds's new Exex VP, Dr. Dhaval Patel will get rid of Neil Weir - another time waster.
     
  15. anonymous

    anonymous Guest

    Is it true Neil Weir was banging Gillian burgess?
     
  16. anonymous

    anonymous Guest

    You never know. But what we do know is that Neil and Gillian fell out and the whole situation had to be dealt with in HR. Apparently Gillian is doing a good job at Vertex now.
     
  17. anonymous

    anonymous Guest

    And now Gillian is at Grunenthal, doing exactly what she did at Pfizer, UCB and Vertex - polarising the whole R&D group, creating enemies out of good and honest scientists (like Alistair Lawson at UCB) and then with her scatty brain antics managing to get a few things done with massive waste. Speak to her ex-reportees and they will just tell you how much they rejoiced when she left their organisations.